[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69403459D1 - Peptidboronsäurederivate mit protease inhibierenden aktivität - Google Patents

Peptidboronsäurederivate mit protease inhibierenden aktivität

Info

Publication number
DE69403459D1
DE69403459D1 DE69403459T DE69403459T DE69403459D1 DE 69403459 D1 DE69403459 D1 DE 69403459D1 DE 69403459 T DE69403459 T DE 69403459T DE 69403459 T DE69403459 T DE 69403459T DE 69403459 D1 DE69403459 D1 DE 69403459D1
Authority
DE
Germany
Prior art keywords
acid derivatives
boronic acid
inhibiting activity
protease inhibiting
peptide boronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69403459T
Other languages
English (en)
Other versions
DE69403459T2 (de
Inventor
Nigel Scott Cook
Rainer Metternich
Carlo Tapparelli
Anette Wienand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939304289A external-priority patent/GB9304289D0/en
Priority claimed from GB939306822A external-priority patent/GB9306822D0/en
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE69403459D1 publication Critical patent/DE69403459D1/de
Publication of DE69403459T2 publication Critical patent/DE69403459T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69403459T 1993-03-03 1994-03-01 Peptidboronsäurederivate mit protease inhibierenden aktivität Expired - Fee Related DE69403459T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939304289A GB9304289D0 (en) 1993-03-03 1993-03-03 Organic compounds
GB939306822A GB9306822D0 (en) 1993-04-01 1993-04-01 Organic compounds
PCT/EP1994/000595 WO1994020526A1 (en) 1993-03-03 1994-03-01 Peptide boronic acid derivatives having protease inhibiting activity

Publications (2)

Publication Number Publication Date
DE69403459D1 true DE69403459D1 (de) 1997-07-03
DE69403459T2 DE69403459T2 (de) 1998-01-02

Family

ID=26302527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69403459T Expired - Fee Related DE69403459T2 (de) 1993-03-03 1994-03-01 Peptidboronsäurederivate mit protease inhibierenden aktivität

Country Status (18)

Country Link
EP (1) EP0688336B1 (de)
JP (1) JPH08507501A (de)
KR (1) KR960701085A (de)
AT (1) ATE153670T1 (de)
AU (1) AU677297B2 (de)
CA (1) CA2153656A1 (de)
DE (1) DE69403459T2 (de)
DK (1) DK0688336T3 (de)
ES (1) ES2101516T3 (de)
GR (1) GR3023577T3 (de)
HU (1) HUT72735A (de)
IL (1) IL108797A0 (de)
MY (1) MY131622A (de)
NZ (1) NZ262415A (de)
PL (1) PL310940A1 (de)
SG (1) SG52766A1 (de)
TW (1) TW329428B (de)
WO (1) WO1994020526A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574014A (en) * 1988-04-28 1996-11-12 Thrombosis Research Institute Inhibitors of trypsin-like enzymes
US6313096B1 (en) 1988-04-28 2001-11-06 Trigen Limited Inhibitors of trypsin-like enzymes
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
GB9502985D0 (en) * 1995-02-16 1995-04-05 Thrombosis Res Inst Enzyme inhibitors
US5612378A (en) * 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US5559150A (en) * 1995-06-06 1996-09-24 3-Dimensional Pharmaceuticals, Inc. N,N-disulfonylated aminobenzene carboxlic acids and the use thereof as thrombin inhibitors
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
US5612369A (en) * 1995-06-07 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Thrombin inhibitors
GB9515489D0 (en) * 1995-07-28 1995-09-27 Sandoz Ltd Organic compounds
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
IL135068A (en) 1997-09-29 2004-03-28 Point Therapeutics Inc Stimulation of hematopoietic cells in vitro
GB9724786D0 (en) * 1997-11-25 1998-01-21 Danbiosyst Uk Oral delivery system
AU770319C (en) 1998-05-04 2004-11-25 Point Therapeutics, Inc. Hematopoietic stimulation
DE69905038T2 (de) 1998-06-05 2003-06-05 Point Therapeutics, Inc. Cyclische boroprolinverbindungen
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
ATE376551T1 (de) 2002-09-09 2007-11-15 Trigen Ltd Peptidborsäuren und deren verwendung in der herstellung von salzen derselben
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
US10526315B2 (en) 2016-06-21 2020-01-07 Orion Ophthalmology LLC Carbocyclic prolinamide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
EP0688336A1 (de) 1995-12-27
HUT72735A (en) 1996-05-28
TW329428B (en) 1998-04-11
ES2101516T3 (es) 1997-07-01
NZ262415A (en) 1996-10-28
DE69403459T2 (de) 1998-01-02
DK0688336T3 (da) 1997-10-20
ATE153670T1 (de) 1997-06-15
AU677297B2 (en) 1997-04-17
AU6208094A (en) 1994-09-26
EP0688336B1 (de) 1997-05-28
GR3023577T3 (en) 1997-08-29
HU9501976D0 (en) 1995-09-28
PL310940A1 (en) 1996-01-08
WO1994020526A1 (en) 1994-09-15
SG52766A1 (en) 1998-09-28
CA2153656A1 (en) 1994-09-15
MY131622A (en) 2007-08-30
JPH08507501A (ja) 1996-08-13
KR960701085A (ko) 1996-02-24
IL108797A0 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
DE69403459D1 (de) Peptidboronsäurederivate mit protease inhibierenden aktivität
DE3878991D1 (de) Peptide boronsaeure-hemmungsstoffe von trypsintyp-proteasen.
MY106529A (en) Series protease inhibitors
DE60022508D1 (de) Inhibitoren von serin proteasen
DE3485568D1 (de) Peptide aus alpha-aminoboronsaeuren.
MY104021A (en) Benzamide protease inhibitors.
DK0815856T3 (da) Retrovirale proteaseinhibitorer
DE69637307D1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
ATE223392T1 (de) Piperazide von substituierten phenylalanin- derivativen als thrombin inhibitoren
ATE170868T1 (de) Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen
ATE71111T1 (de) Peptid-derivate, renin- und saeureprotease hemmende mittel.
DE69326077D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen
ATE260112T1 (de) Amidino proteaseinhibitoren
ATE279432T1 (de) Kininogen-inhibitoren
TW223630B (en) Retroviral protease inhibitors
ATE131066T1 (de) Mittel zur hemmung von hiv-proteasen.
CZ92298A3 (cs) Inhibitory guanidin proteasy
DE68917837D1 (de) Peptid-Verbindungen.
DE59812724D1 (de) Serin-proteinase-inhibitoren
ATE148105T1 (de) Succinoylaminohydroxyäthylaminosulfamidsäureder vate und ihre verwendung als retrovirale proteasehemmer
FR2676059B1 (fr) Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee